The Highest-ROI Investment a Business Owner Can Make (It’s Not in Your Portfolio)
If exercise existed as a pharmaceutical compound, it would be the most prescribed drug in history. It is also the most underprescribed — particularly among the people who arguably need it most.
There is a category of investment that sophisticated capital allocators think about differently from most people: asymmetric bets with outsized, compounding returns. The kind where a relatively small, consistent commitment yields disproportionate long-term outcomes — not through a single high-variance event, but through the quiet, relentless accumulation of compounding gains.
Exercise is that investment for your biology.
This is not a wellness platitude. It is one of the most well-supported findings in longevity research, and it has a specificity that most health advice lacks. Peter Attia, whose work synthesizes decades of data on what actually determines how long people live and how well they function as they age, makes a blunt claim: no other tactical intervention comes close to exercise in its impact on both lifespan and healthspan. Not nutrition, not supplements, not any pharmaceutical currently available.
The data behind this claim is worth understanding — not because the conclusion is surprising, but because understanding the mechanism changes how you think about why you’re doing it and what kind of exercise actually matters.
The Number That Changes Everything
Among the many metrics that predict longevity, one stands out with unusual consistency across the research: cardiorespiratory fitness, typically measured as VO₂ max — the maximum rate at which your body can utilize oxygen during sustained exercise.
VO₂ max is not a niche biohacking metric. It is, in the longevity literature, one of the strongest predictors of all-cause mortality — stronger, in many studies, than smoking status, blood pressure, or cholesterol levels. A study published in JAMA Network Open found that people in the lowest quintile of cardiorespiratory fitness had a mortality risk more than five times higher than those in the highest quintile. Moving from the bottom quintile to just above average was associated with a larger reduction in mortality risk than most pharmaceutical interventions achieve.
The reason VO₂ max matters so much is that it reflects the integrated efficiency of your cardiovascular, pulmonary, and muscular systems. A high VO₂ max means your heart pumps effectively, your arteries are in good condition, your muscles extract and utilize oxygen efficiently, and your mitochondria — the organelles that produce cellular energy — are numerous and functional. These are not independent variables; they are the biological substrate of high function, and they deteriorate with age at a rate that is significantly modulated by how much and how you exercise.
The critical point: VO₂ max is trainable. It is not fixed by genetics. Consistent aerobic exercise can improve it substantially at any age, and maintaining it through middle age and into later life delays the onset of functional decline by years.
Strength: The Ignored Half of the Equation
If cardiorespiratory fitness is the most undervalued health metric, muscle mass and strength are close behind it.
The data on muscle as a longevity variable is increasingly compelling. Grip strength — a crude but remarkably consistent proxy for overall muscle strength — is an independent predictor of mortality across multiple large studies. Sarcopenia, the age-related loss of muscle mass, is strongly associated with frailty, falls, metabolic dysfunction, and reduced survival. And because muscle mass declines steadily after approximately age forty, the amount of muscle you build and maintain in your thirties, forties, and fifties determines the floor from which you will be working in your seventies and eighties.
Muscle is also metabolically active in ways that matter. It is the primary site of glucose disposal — the tissue responsible for absorbing blood glucose in response to insulin. Higher muscle mass means better insulin sensitivity, which reduces metabolic dysfunction risk and, downstream, the risk of cardiovascular disease, cancer, and Alzheimer’s. A person with significant muscle mass has a substantially larger metabolic reserve against the development of type 2 diabetes than an otherwise similar person without it.
The practical implication for a business owner is simple: resistance training is not vanity. It is metabolic infrastructure. Building and maintaining it is one of the highest-leverage investments you can make in your long-term physiological function.
Cognitive Performance: The Direct Line
For a founder, the most immediate return on exercise is not physical. It is cognitive.
The evidence on exercise and brain function is extensive and consistent. Aerobic exercise increases production of brain-derived neurotrophic factor (BDNF), a protein that promotes the growth of new neurons and synaptic connections, particularly in the hippocampus — the brain region most involved in memory and learning. It improves cerebral blood flow, reduces neuroinflammation, and enhances the efficiency of prefrontal cortex function, which governs decision-making, impulse control, and complex reasoning.
These are not effects that accrue only over years. Acute exercise — a single session of moderate aerobic activity — produces measurable improvements in memory consolidation, attention, and executive function that persist for several hours. Regular exercise is associated with meaningfully lower rates of cognitive decline in aging populations and with reduced Alzheimer’s risk through multiple mechanisms.
Put differently: the clearest thinking you will do on a given day is more likely to happen after you exercise than without it. The hours recovered in cognitive performance may well exceed the time invested in the workout itself.
What Kind of Exercise, and How Much?
Attia’s framework for exercise is built around a concept he calls the “Centenarian Decathlon” — not a literal athletic event, but a mental model. The question it asks is: what physical activities do you want to be able to perform in your eighties and nineties? And what does that require you to be capable of today, working backward through the expected trajectory of physical decline?
If you want to be able to hike at seventy-five, carry luggage at eighty, play with grandchildren at eighty-five — what level of cardiorespiratory fitness, strength, and mobility do you need at fifty? The answer, consistently, is higher than most people aim for. Age-related decline in VO₂ max and muscle mass is approximately ten percent per decade after forty, meaning that a person who is merely “adequate” in their fifties will likely be functionally impaired in their seventies. The margin you build now is the margin you draw down later.
The practical framework involves four areas: Zone 2 aerobic training (sustained moderate-intensity cardio, ideally 150-200 minutes per week), high-intensity interval training for VO₂ max development, resistance training for muscle strength and mass, and stability and mobility work to reduce injury risk and maintain functional movement patterns.
None of this requires elite athleticism. The gains are largest for people moving from sedentary to moderately active. The most important variable is not the specific protocol — it is consistency, sustained over years.
The Real Cost of Not Exercising
The standard framing of exercise as a health practice — something virtuous and beneficial that you should probably do more of — severely undersells it. The more accurate framing is that not exercising is a risk factor, with quantifiable consequences for lifespan, cognitive function, metabolic health, and cardiovascular risk.
A business owner who is too busy to exercise is making a trade that most investors would immediately identify as a bad deal: sacrificing a high-confidence, compounding long-term asset for marginal gains in short-term output. The irony is that the short-term gain is largely illusory. The research on exercise and cognitive performance suggests that executives who exercise regularly are not less productive — they are more productive, with clearer decision-making, better stress regulation, and higher sustained energy.
The question is not whether you can afford to exercise. It is whether you can afford not to.
The Blue connects science-backed longevity innovation with the capital and frameworks needed to scale it. This article is part of a series exploring the intersection of longevity science and high-performance leadership.